36 pharmaceutical firms’ debt ratio hovers at 57% on average

Published: 2011-05-18 06:59:00

Updated: 2011-05-18 06:59:00

The debt ratio of the KOSPI-listed 36 pharmaceutical firms in the country averaged 57 percent as of the end of last year, down 2 percentage points from 2009, according to Yakup.com, a pharmaceutical information provider,

The debt ratio, or the ratio of debt to equity, is used to measure the f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK